RFK Jr.'s NIH Funds Study on Ivermectin as Cancer Treatment, Drawing Expert Criticism
The National Institutes of Health, now under the influence of Robert F. Kennedy Jr., is funding a study investigating whether the dewormer ivermectin can cure cancer. Medical experts and researchers have sharply criticized the study as "absurd," noting there is no credible scientific evidence to suggest ivermectin has anti-cancer properties in humans.
The move reflects broader concerns about the direction of federal health research under RFK Jr.'s leadership, which critics say is being steered by ideological commitments rather than scientific merit. Ivermectin became a politically charged topic during the COVID-19 pandemic when it was promoted by some as an alternative treatment despite lack of evidence. Directing NIH funding toward such studies risks diverting resources from legitimate cancer research and further eroding public trust in federal health institutions.
The move reflects broader concerns about the direction of federal health research under RFK Jr.'s leadership, which critics say is being steered by ideological commitments rather than scientific merit. Ivermectin became a politically charged topic during the COVID-19 pandemic when it was promoted by some as an alternative treatment despite lack of evidence. Directing NIH funding toward such studies risks diverting resources from legitimate cancer research and further eroding public trust in federal health institutions.